 | • レポートコード：D0804-05130 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、慢性腎臓病（CKD）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性腎臓病（CKD）治療薬の種類別市場規模（ACE阻害剤、アンジオテンシン-II受容体遮断薬、カルシウムチャンネル遮断薬、ベータ遮断薬：ブレビブロック、バイストリック、その他）、用途別市場規模（病院、専門クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer, Inc.、GlaxoSmithKline (GSK)、Amgen、Kissei Pharmaceutical Co., Ltd.、Roche、AbbVie、Allergan ・地域別グローバル市場分析 2015年-2020年 ・慢性腎臓病（CKD）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・慢性腎臓病（CKD）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・慢性腎臓病（CKD）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・慢性腎臓病（CKD）治療薬の南米市場（ブラジル、アルゼンチン） ・慢性腎臓病（CKD）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ACE阻害剤、アンジオテンシン-II受容体遮断薬、カルシウムチャンネル遮断薬、ベータ遮断薬：ブレビブロック、バイストリック、その他 ・用途別分析：病院、専門クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Chronic Kidney Disease (CKD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Chronic Kidney Disease (CKD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chronic Kidney Disease (CKD) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chronic Kidney Disease (CKD) Drugs market has been segmented into
ACE inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers: BREVIBLOC, Bystolic
Others
By Application, Chronic Kidney Disease (CKD) Drugs has been segmented into:
Hospitals
Specialty Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Kidney Disease (CKD) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Kidney Disease (CKD) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Kidney Disease (CKD) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Chronic Kidney Disease (CKD) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Chronic Kidney Disease (CKD) Drugs Market Share Analysis
Chronic Kidney Disease (CKD) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Kidney Disease (CKD) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Kidney Disease (CKD) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Chronic Kidney Disease (CKD) Drugs are:
Pfizer, Inc.
GlaxoSmithKline (GSK)
Amgen
Kissei Pharmaceutical Co., Ltd.
Roche
AbbVie
Allergan
Among other players domestic and global, Chronic Kidney Disease (CKD) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Kidney Disease (CKD) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Kidney Disease (CKD) Drugs, with price, sales, revenue and global market share of Chronic Kidney Disease (CKD) Drugs in 2018 and 2019.
Chapter 3, the Chronic Kidney Disease (CKD) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Kidney Disease (CKD) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Chronic Kidney Disease (CKD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Chronic Kidney Disease (CKD) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Chronic Kidney Disease (CKD) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Kidney Disease (CKD) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ACE inhibitors
1.2.3 Angiotensin-II receptor blockers
1.2.4 Calcium channel blockers
1.2.5 Beta blockers: BREVIBLOC, Bystolic
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Kidney Disease (CKD) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Overview of Global Chronic Kidney Disease (CKD) Drugs Market
1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Pfizer, Inc. Details
2.1.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer, Inc. SWOT Analysis
2.1.4 Pfizer, Inc. Product and Services
2.1.5 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline (GSK)
2.2.1 GlaxoSmithKline (GSK) Details
2.2.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline (GSK) SWOT Analysis
2.2.4 GlaxoSmithKline (GSK) Product and Services
2.2.5 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Kissei Pharmaceutical Co., Ltd.
2.4.1 Kissei Pharmaceutical Co., Ltd. Details
2.4.2 Kissei Pharmaceutical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Kissei Pharmaceutical Co., Ltd. SWOT Analysis
2.4.4 Kissei Pharmaceutical Co., Ltd. Product and Services
2.4.5 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Allergan SWOT Analysis
2.7.4 Allergan Product and Services
2.7.5 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Chronic Kidney Disease (CKD) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Chronic Kidney Disease (CKD) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
6.4 France Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7.5 India Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Chronic Kidney Disease (CKD) Drugs Price by Type (2015-2020)
11 Global Chronic Kidney Disease (CKD) Drugs Market Segment by Application
11.1 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Chronic Kidney Disease (CKD) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Chronic Kidney Disease (CKD) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025)
12.2.2 Europe Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025)
12.2.4 South America Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025)
12.3 Chronic Kidney Disease (CKD) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Chronic Kidney Disease (CKD) Drugs Market Share Forecast by Type (2021-2025)
12.4 Chronic Kidney Disease (CKD) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Chronic Kidney Disease (CKD) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Chronic Kidney Disease (CKD) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Kidney Disease (CKD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Kidney Disease (CKD) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Major Business
Table 9. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer, Inc. SWOT Analysis
Table 11. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product and Services
Table 12. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Major Business
Table 15. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. GlaxoSmithKline (GSK) SWOT Analysis
Table 17. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product and Services
Table 18. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Chronic Kidney Disease (CKD) Drugs Major Business
Table 21. Amgen Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Amgen SWOT Analysis
Table 23. Amgen Chronic Kidney Disease (CKD) Drugs Product and Services
Table 24. Amgen Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Kissei Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Major Business
Table 27. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Kissei Pharmaceutical Co., Ltd. SWOT Analysis
Table 29. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product and Services
Table 30. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Chronic Kidney Disease (CKD) Drugs Major Business
Table 33. Roche Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Chronic Kidney Disease (CKD) Drugs Product and Services
Table 36. Roche Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AbbVie Basic Information, Manufacturing Base and Competitors
Table 38. AbbVie Chronic Kidney Disease (CKD) Drugs Major Business
Table 39. AbbVie Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. AbbVie SWOT Analysis
Table 41. AbbVie Chronic Kidney Disease (CKD) Drugs Product and Services
Table 42. AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Chronic Kidney Disease (CKD) Drugs Major Business
Table 45. Allergan Chronic Kidney Disease (CKD) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Allergan SWOT Analysis
Table 47. Allergan Chronic Kidney Disease (CKD) Drugs Product and Services
Table 48. Allergan Chronic Kidney Disease (CKD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Chronic Kidney Disease (CKD) Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Chronic Kidney Disease (CKD) Drugs Sales by Regions (2015-2020) (K Units)
Table 52. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions (2015-2020)
Table 53. Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Chronic Kidney Disease (CKD) Drugs Sales by Countries (2015-2020) (K Units)
Table 55. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2015-2020)
Table 56. North America Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020)
Table 58. Europe Chronic Kidney Disease (CKD) Drugs Sales by Countries (2015-2020) (K Units)
Table 59. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2015-2020)
Table 60. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Chronic Kidney Disease (CKD) Drugs Sales by Countries (2015-2020) (K Units)
Table 65. South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2015-2020)
Table 66. South America Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020)
Table 72. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 73. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2015-2020)
Table 74. Global Chronic Kidney Disease (CKD) Drugs Revenue by Type (2015-2020) (USD Million)
Table 75. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2015-2020)
Table 76. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 77. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Application (2015-2020)
Table 78. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Chronic Kidney Disease (CKD) Drugs Market Share Forecast by Regions (2021-2025)
Table 80. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Chronic Kidney Disease (CKD) Drugs Market Share Forecast by Type (2021-2025)
Table 82. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2021-2025)
Table 83. Global Chronic Kidney Disease (CKD) Drugs Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Chronic Kidney Disease (CKD) Drugs Picture
Figure 2. Global Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2019
Figure 3. ACE inhibitors Picture
Figure 4. Angiotensin-II receptor blockers Picture
Figure 5. Calcium channel blockers Picture
Figure 6. Beta blockers: BREVIBLOC, Bystolic Picture
Figure 7. Others Picture
Figure 8. Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2018
Figure 9. Hospitals Picture
Figure 10. Specialty Clinics Picture
Figure 11. Global Chronic Kidney Disease (CKD) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Chronic Kidney Disease (CKD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Chronic Kidney Disease (CKD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Chronic Kidney Disease (CKD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries in 2018
Figure 48. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions 2019
Figure 64. China Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries in 2019
Figure 71. South America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Chronic Kidney Disease (CKD) Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
慢性閉塞性肺疾患治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Obstructive Pulmonary Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The C…- アンジオテンシン受容体遮断薬（ARB）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Blockers (ARBs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angioten…
- 常染色体優性多発性嚢胞腎疾患治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Autosomal Dominant Polycystic Kidney Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market p…
- デント病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dent Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- ウィルソン病治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Wilson's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wilson's Disease Drugs…